Community Research and Development Information Service - CORDIS

Feasibility study for clinical validation of NTproCNP as a novel biomarker for pregnancy complications

From 2015-07-01 to 2015-10-31, closed project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

Austria

Call for proposal:

H2020-SMEINST-1-2015See other projects for this call

Funding scheme:

SME-1 - SME instrument phase 1

Objective

Coordinator

THE ANTIBODY LAB GMBH
Austria

EU contribution: EUR 50 000


DIVISCHGASSE 4
1210 WIEN
Austria
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 197405 / Last updated on: 2015-12-07